MediPress Health-Limited Partnership
MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various … Read more
Market Cap & Net Worth: MediPress Health-Limited Partnership (MPRS)
MediPress Health-Limited Partnership (TA:MPRS) has a market capitalization of $1.36K (ILA506.01K) as of March 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #47762 globally and #467 in its home market, demonstrating a 1.51% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MediPress Health-Limited Partnership's stock price ILA53.90 by its total outstanding shares 9388 (9.39K).
MediPress Health-Limited Partnership Market Cap History: 2021 to 2026
MediPress Health-Limited Partnership's market capitalization history from 2021 to 2026. Data shows change from $4.89K to $1.36K (-26.29% CAGR).
MediPress Health-Limited Partnership Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MediPress Health-Limited Partnership's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MPRS by Market Capitalization
Companies near MediPress Health-Limited Partnership in the global market cap rankings as of March 18, 2026.
Key companies related to MediPress Health-Limited Partnership by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
MediPress Health-Limited Partnership Historical Marketcap From 2021 to 2026
Between 2021 and today, MediPress Health-Limited Partnership's market cap moved from $4.89K to $ 1.36K, with a yearly change of -26.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA1.36K | +8.89% |
| 2025 | ILA1.25K | -30.87% |
| 2024 | ILA1.80K | -22.59% |
| 2023 | ILA2.33K | +43.63% |
| 2022 | ILA1.62K | -66.84% |
| 2021 | ILA4.89K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of MediPress Health-Limited Partnership was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.36K USD |
| MoneyControl | $1.36K USD |
| MarketWatch | $1.36K USD |
| marketcap.company | $1.36K USD |
| Reuters | $1.36K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.